For many cannabis founders, the exit problem is not finding the right buyer. It is that there are barely any buyers at all. The field is narrow, capital is tight, and the strategic buyers that do exist are rarely showing up with clean cash offers. More often, founders are being asked to accept low valuations, seller paper, stock in the buyer, or some other compromise that falls short of a real exit.

That leaves owners in a bad spot. They can sell on terms they do not like and watch the company they built get absorbed into a larger platform. Or they can keep running the business and hope the market improves. Neither is a strong answer for a founder who wants liquidity now.

For years, the industry has told itself a familiar story. Survive the chaos, build something real, wait for institutional capital, and eventually a good buyer will show up. It is a nice story. It just has not been true for most operators.

Cannabis does not have a deep buyer universe. 

Most private equity firms have stayed away from plant-touching companies because there is no clear exit path. Most large strategic buyers have their own capital constraints, which means they buy selectively and often on terms that shift risk back to the seller. At the same time, 280E has drained cash from otherwise solid businesses, making it harder for founders to wait around for a market that may or may not improve.

That is why so many owners have been stuck in the same position for years: they have built valuable businesses, but when they want liquidity, the options are limited, and the terms are often weak. “Hold on, and the buyers will come” is not much of a plan.

In a strategic sale, the business usually gets folded into the buyer’s system. 

That means integration, overlap, and eventually cuts. Redundant roles are eliminated. Decisions get centralized. The team that built the business often does not survive the transition intact, not because they did anything wrong, but because that is how acquisitions work.

That is especially important in cannabis because so much of a company’s value sits with the people who know how to run it. Licenses matter. Facilities matter. But so do the founders, operators, and key managers who understand compliance, vendor relationships, local markets, and the day-to-day realities of staying alive in a difficult industry. A buyer can acquire the company, but it cannot instantly replace the people who made it work.

The Independent Buyout is the savior

Most founders do not even know there is another path. In cannabis, the conversation is usually framed as either selling your company to a strategic buyer or keeping it going. But there is a third option: selling shares to an employee ownership trust through an ESOP. It is called an “Independent Buyout” because that is what it actually is. The founder gets liquidity. The company stays independent. No private equity. Leadership stays in place.

The process is more straightforward than most people think. The company is valued, the purchase price is negotiated, and the founder sells some or all of the stock to the trust. In most cases, the founder receives cash at closing and seller notes for the balance. The company then uses its future cash flow to pay down the transaction over time. The important difference is that the buyer is not a strategic acquirer looking to absorb the company. The buyer is a trust set up for the employees, which allows the company to keep operating as its own business.

An Independent Buyout gives founders flexibility and tax breaks

They do not have to sell everything at once. A minority sale can allow an owner to take meaningful liquidity off the table while continuing to run the company and keeping future upside. For a founder who has spent years reinvesting earnings back into the business and wants some personal liquidity without walking away, that matters.

There is also a tax advantage that is hard to ignore in cannabis. A company that becomes 100% ESOP-owned can operate free of federal and state income tax. In practical terms, that means cash that would have gone out the door in taxes can instead be used to pay down debt, support operations, and fund growth. In this industry, that is a major shift.

One of the biggest differences in an Independent Buyout is that leadership usually stays in place. That matters because cannabis businesses are not easy to hand off. Much of the knowledge that keeps the company running is sitting inside the heads of the people already there. When those people leave, performance often suffers at exactly the moment stability is needed most. An Independent Buyout helps avoid that disruption by keeping experienced leadership in the business after the transaction closes.

This is not for every company. If a founder wants a clean break and there is no leadership team to keep running the business, a traditional sale may be the better route. But for founders who want liquidity without handing the company over to a weak buyer on weak terms, the Independent Buyout is a real alternative.

The post The Third Exit Path for Cannabis Founders appeared first on Cannabis Industry Journal.